Knud Kragballe - Publications, H-index & Citations

Knud Kragballe

Aarhus University

59H指数

435论文数

1.3W被引数

收录论文 81

发表时间

Association Between Changes in Coronary Artery Disease Progression and Treatment With Biologic Agents for Severe Psoriasis

JAMA DERMATOLOGY

IF11

2016-10-01

OAAI

Hjuler, Kasper Fjellhaugen; Bottcher, Morten; Vestergaard, Christian; Botker, Hans Erik; Iversen, Lars; Kragballe, Knud

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2016-08-12

PREAI

Augustin, M.; Blome, C.; Paul, C.; Puig, L.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Kragballe, K.; Naessens, D.; Bergmans, P.; Smirnov, P.; Barker, J.; Reich, K.

Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2016-02-08

PREAI

Vinter, H.; Kragballe, K.; Steiniche, T.; Gaestel, M.; Iversen, L.; Johansen, C.

Aldara®-induced skin inflammation: studies of patients with psoriasis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2014-12-10

PREAI

Vinter, H.; Iversen, L.; Steiniche, T.; Kragballe, K.; Johansen, C.

Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis

INTERNATIONAL JOURNAL OF DERMATOLOGY

IF3.2

2014-06-25

PREAI

Bertelsen, Trine; Kragballe, Knud; Johansen, Claus; Iversen, Lars

Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin

EXPERIMENTAL DERMATOLOGY

IF3.1

2014-04-28

PREAI

Bech, Rikke; Otkjaer, Kristian; Birkelund, Svend; Vorup-Jensen, Thomas; Agger, Ralf; Johansen, Claus; Iversen, Lars; Kragballe, Knud; Romer, John

One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2014-02-18

OAAI

Reich, K.; Puig, L.; Paul, C.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J. -F.; Rizova, E.; Brunori, M.; Mistry, S.; Bergmans, P.; Barker, J.

Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2014-02-01

OAAI

Paul, C.; Puig, L.; Kragballe, K.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J. -F.; Rizova, E.; Lavie, F.; Mistry, S.; Bergmans, P.; Barker, J.; Reich, K.

Implementing Best Practice in Psoriasis: A Nordic Expert Group Consensus

ACTA DERMATO-VENEREOLOGICA

IF3.7

2014-01-01

OAAI

Kragballe, Knud; Gniadecki, Robert; Mork, Nils-Jorgen; Rantanen, Tapio; Stahle, Mona

Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity

EXPERIMENTAL DERMATOLOGY

IF3.1

2013-04-25

PREAI

Andres, Rosa M.; Hald, Anne; Johansen, Claus; Kragballe, Knud; Iversen, Lars

A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2013-02-26

128

OAAI

Mrowietz, U.; de Jong, E. M. G. J.; Kragballe, K.; Langley, R.; Nast, A.; Puig, L.; Reich, K.; Schmitt, J.; Warren, R. B.

The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2013-01-30

PREAI

Kjellerup, R. B.; Johansen, C.; Kragballe, K.; Iversen, L.

Treatment Patterns, Treatment Satisfaction, Severity of Disease Problems, and Quality of Life in Patients with Psoriasis in Three Nordic Countries

ACTA DERMATO-VENEREOLOGICA

IF3.7

2013-01-01

OAAI

Tennvall, Gunnel Ragnarson; Hjortsberg, Catharina; Bjarnason, Anton; Gniadecki, Robert; Heikkila, Hannele; Jemec, Gregor B. E.; Kragballe, Knud; Miller, Iben M.; Svensson, Ake

IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab

ACTA DERMATO-VENEREOLOGICA

IF3.7

2013-01-01

OAAI

Gedebjerg, Anne; Johansen, Claus; Kragballe, Knud; Iversen, Lars

Ustekinumab in the Treatment of Refractory Chronic Cutaneous Lupus Erythematosus: A Case Report

ACTA DERMATO-VENEREOLOGICA

IF3.7

2013-01-01

PREAI

Dahl, Christine; Johansen, Claus; Kragballe, Knud; Olesen, Anne Braae

An assessment of adalimumab efficacy in three Phase III clinical trials using the European Consensus Programme criteria for psoriasis treatment goals

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2012-12-13

PREAI

Mrowietz, U.; Kragballe, K.; Reich, K.; Griffiths, C. E. M.; Gu, Y.; Wang, Y.; Rozzo, S. J.

LONG-TERM IMPROVEMENT IN PATIENT-REPORTED OUTCOMES AFTER TRANSITION FROM METHOTREXATE TO USTEKINUMAB IN MODERATE TO SEVERE PSORIASIS: TRANSIT WEEK 52 RESULTS

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Reich, K.; Puig, L.; Luger, T.; Lambert, J.; Chimenti, S.; Girolomoni, G.; Nicolas, J. F.; Kragballe, K.; Mistry, S.; Bergmans, P.; Thompson, G.; Barker, J.; Paul, C.

Atopic Dermatitis and Risk of Skin Cancer A Danish Nationwide Cohort Study (1977-2006)

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

IF8.8

2012-02-01

PREAI

Jensen, Annette O.; Svaerke, Claus; Farkas, Dora Kormendine; Olesen, Anne B.; Kragballe, Knud; Sorensen, Henrik T.

CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways

CYTOKINE

IF3.7

2011-12-01

PREAI

Riis, Jette Lindorff; Johansen, Claus; Vestergaard, Christian; Otkjaer, Kristian; Kragballe, Knud; Iversen, Lars